| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012133648 |
| P356 | DOI | 10.1186/S12879-016-1783-9 |
| P932 | PMC publication ID | 5010739 |
| P698 | PubMed publication ID | 27589847 |
| P50 | author | Marc J. M. Bonten | Q87138620 |
| Marie-Josée J Mangen | Q43015397 | ||
| G. Ardine de Wit | Q60669638 | ||
| P2093 | author name string | Susanne M Huijts | |
| Conrad E Vissink | |||
| P2860 | cites work | Clinical and economic burden of community-acquired pneumonia among adults in Europe | Q22242008 |
| [Community-acquired pneumonia: a disease of the elderly] | Q84744495 | ||
| Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study | Q24678793 | ||
| New trends in the prevention and management of community-acquired pneumonia | Q27011619 | ||
| A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin | Q28145205 | ||
| A prediction rule to identify low-risk patients with community-acquired pneumonia | Q28301165 | ||
| Pneumonia burden in elderly patients: a classification algorithm using administrative data | Q30701239 | ||
| Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis | Q33831860 | ||
| A clinical pathway for community-acquired pneumonia: an observational cohort study | Q33953008 | ||
| Trends in Mortality and Medical Spending in Patients Hospitalized for Community-Acquired Pneumonia | Q34721949 | ||
| Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia | Q34937466 | ||
| Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands | Q36571135 | ||
| Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years | Q36875124 | ||
| Economic burden and epidemiology of pneumonia in Korean adults aged over 50 years | Q36917172 | ||
| Increasing hospital admissions for pneumonia, England | Q37009138 | ||
| Risk factors for community-acquired pneumonia in adults in Europe: a literature review | Q37267627 | ||
| Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults | Q37319888 | ||
| New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality | Q37433579 | ||
| Epidemiology of community-acquired pneumonia in older adults: a population-based study | Q37856563 | ||
| Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population | Q38429560 | ||
| Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia | Q39471556 | ||
| Update of the Dutch Manual for Costing in Economic Evaluations | Q39621207 | ||
| Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis. | Q40932197 | ||
| Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. | Q41415380 | ||
| Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin? | Q43595159 | ||
| Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. | Q44185151 | ||
| National Hospital Discharge Survey: 2007 summary | Q46693529 | ||
| Cost analyses of community-acquired pneumonia from the hospital perspective | Q46763837 | ||
| Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia. | Q50899872 | ||
| Incidence and cost of pneumonia in medicare beneficiaries. | Q51180810 | ||
| Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. | Q51723820 | ||
| International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. | Q53233491 | ||
| A decision chart for assessing and improving the transferability of economic evaluation results between countries. | Q53286025 | ||
| [The increase in pneumonia-related morbidity and mortality among adults in the Netherlands and possible explanations for it] | Q53882191 | ||
| A population-based study of the costs of care for community-acquired pneumonia | Q58478082 | ||
| Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia | Q73044928 | ||
| [Costs of illness and health-related quality of life for community-acquired pneumonia--a systematic review] | Q83932555 | ||
| P2507 | corrigendum / erratum | Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study | Q42363418 |
| P921 | main subject | pneumonia | Q12192 |
| hospitalization | Q3140971 | ||
| P304 | page(s) | 466 | |
| P577 | publication date | 2016-09-02 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study | |
| P478 | volume | 16 |
| Q88964567 | A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands |
| Q38795421 | Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine |
| Q91829437 | Cost-Effectiveness Of Culture-Based Versus Empirical Antibiotic Treatment For Hospitalized Adults With Community-Acquired Pneumonia In Indonesia: A Real-World Patient-Database Study |
| Q38762048 | Costs associated with community acquired pneumonia in France |
| Q42363418 | Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study |
| Q60043953 | Estimating severity of influenza epidemics from severe acute respiratory infections (SARI) in intensive care units |
| Q92704922 | Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50 years-old |
| Q90374226 | Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study |
| Q60934660 | Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumonia |
| Q64917638 | Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy. |
| Q92540447 | Progression of the Radiologic Severity Index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia |
| Q55267236 | Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly. |
| Q42363418 | Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study | main subject | P921 |
Search more.